Chrysin protects against renal ischemia reperfusion induced tubular cell apoptosis and inflammation in mice
Mingwei Xu, Hongbo Shi, Dongcao Liu.
EXP THER MED. 2019 Jan 21;2256-2262.
引用產(chǎn)品:abs120616 Rabbit Anti-MPO Polyclonal Antibody, abs957 即用型免疫組化二抗試劑盒
影響因子:1.410
The effects of interleukin 17A on left stellate ganglion remodeling are mediated by neuroimmune communication in normal structural hearts
Jielin Deng, Xiaoya Zhou, Menglong Wang, Meng Wang, Liping Zhou, Guannan Meng, Yuhong Wang, Zhenya Wang, Yifeng Zhang, Zhen Zhou, Lilei Yu, Hong Jiang.
International Journal of Cardiology. 2019 Mar 15;279(15):64-71.
引用產(chǎn)品:abs130700 Phospho-Trk A (Tyr680+Tyr681) Antibody
影響因子:4.034
Downregulation of G2/mitotic-specific cyclinB1 triggers autophagy via AMPK-ULK1-dependent signal pathway in nasopharyngeal carcinoma cells
Xianhe Xie, Wanzun Lin, Weili Zheng, Ting Chen, Haitao Yang, Lijun Sun, Fei Huang, Zili Wang, Heng Lin, Long Chen, Jun Liu, Liyan Yang.
Cell Death Dis. 2019 Jan 30;10(2):94.
引用產(chǎn)品:abs920 ECL化學(xué)發(fā)光檢測試劑盒
Exosomes derived from mesenchymal stem cells attenuate inflammation and demyelination of the central nervous system in EAE rats by regulating the polarization of microglia
Zijian Li, Fei Liu, Xin He, Xue Yang, Fengping Shan, Juan Feng.
International Immunopharmacology. 2019 Feb 01;67:268-280.
引用產(chǎn)品:abs20023 Goat anti-Rabbit IgG-FITC
影響因子:3.118
Efficient Cholera Toxin B Subunit‐Based Nanoparticles with MRI Capability for Drug Delivery to the Brain Following Intranasal Administration
Yiming Chen, Huimin Fan, Chen Xu, Wenli Hu, Bingran Yu.
Macromol Biosci. 2018 Dec 07;19(2).
引用產(chǎn)品:abs80001 霍亂毒素B亞單位
影響因子:3.392
相關(guān)產(chǎn)品
免責(zé)聲明
- 凡本網(wǎng)注明“來源:化工儀器網(wǎng)”的所有作品,均為浙江興旺寶明通網(wǎng)絡(luò)有限公司-化工儀器網(wǎng)合法擁有版權(quán)或有權(quán)使用的作品,未經(jīng)本網(wǎng)授權(quán)不得轉(zhuǎn)載、摘編或利用其它方式使用上述作品。已經(jīng)本網(wǎng)授權(quán)使用作品的,應(yīng)在授權(quán)范圍內(nèi)使用,并注明“來源:化工儀器網(wǎng)”。違反上述聲明者,本網(wǎng)將追究其相關(guān)法律責(zé)任。
- 本網(wǎng)轉(zhuǎn)載并注明自其他來源(非化工儀器網(wǎng))的作品,目的在于傳遞更多信息,并不代表本網(wǎng)贊同其觀點和對其真實性負(fù)責(zé),不承擔(dān)此類作品侵權(quán)行為的直接責(zé)任及連帶責(zé)任。其他媒體、網(wǎng)站或個人從本網(wǎng)轉(zhuǎn)載時,必須保留本網(wǎng)注明的作品第一來源,并自負(fù)版權(quán)等法律責(zé)任。
- 如涉及作品內(nèi)容、版權(quán)等問題,請在作品發(fā)表之日起一周內(nèi)與本網(wǎng)聯(lián)系,否則視為放棄相關(guān)權(quán)利。